Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics

@article{Giegling2017GeneticsOS,
  title={Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics},
  author={Ina Giegling and Ladislav Hos{\'a}k and Rainald Mössner and Alessandro Serretti and Frank Bellivier and Stephan Claes and David A. Collier and Alejo Corrales and Lynn E. DeLisi and Carla Gallo and Michael Gill and James L. Kennedy and Marion Leboyer and Wolfgang Maier and Miguel M{\'a}rquez and Isabelle Massat and Ole Mors and Pierandrea Muglia and Markus M. N{\"o}then and Jorge Ospina-Duque and Michael J. Owen and P. Propping and Yongyong Shi and David St. Clair and Florence Thibaut and Sven Cichon and Julien Mendlewicz and Michael C. O’Donovan and Dan Rujescu},
  journal={The World Journal of Biological Psychiatry},
  year={2017},
  volume={18},
  pages={492 - 505}
}
Abstract Objectives: Schizophrenia is a severe psychiatric disease affecting about 1% of the general population. The relative contribution of genetic factors has been estimated to be up to 80%. The mode of inheritance is complex, non-Mendelian, and in most cases involving the combined action of large numbers of genes. Methods: This review summarises recent efforts to identify genetic variants associated with schizophrenia detected, e.g., through genome-wide association studies, studies on copy… Expand
Genetik der Schizophrenie // Genetics in schizophrenia
TLDR
A large, new body of evidence on genetics of schizophrenia is expected through next generation sequencing techniques, which could help to improve diagnostics and early detection and to adapt drug treatment on the genetic profile of patients. Expand
Genetics of schizophrenia (Review)
TLDR
The following article reunites some genetic, epigenetic and environmental factors of schizophrenia from revered and vast studies in a chronological and progressive fashion. Expand
[Genetics and epigenetics of schizophrenia and other psychoses].
TLDR
The recent advances in the genetics and epigenetics of psychosis are promising and could open the way to a recategorization of these disorders as well as the identification of new therapeutic targets. Expand
Attempts to replicate genetic associations with schizophrenia in a cohort from north India
TLDR
A tenuous link between schizophrenia’s genetic basis in Caucasians and Indians calls for more comprehensive research on the latter, with a clear need for more schizophrenia genetic studies in India. Expand
A contemporary view on the molecular basis of neurodevelopmental disorders
TLDR
Historical overview of how major technological advances in the last two decades have drastically increased the resolution of genetic aberration detection is provided to strengthen the hypothesis that neurodevelopmental disorders are part of a continuous phenotypic spectrum rather than separate disease entities. Expand
Discovery biology of neuropsychiatric syndromes (DBNS): a center for integrating clinical medicine and basic science
TLDR
In a proportion of subjects, it is expected these neuro-endophenotypes to progress over time and to predict treatment outcome and the repository of biomaterials as well as digital datasets of clinical parameters will serve as a valuable resource for the broader scientific community who wish to address research questions. Expand
Schizophrenia risk variants influence multiple classes of transcripts of sorting nexin 19 (SNX19)
TLDR
Findings indicate a potentially complex molecular etiology, in which risk alleles for schizophrenia generate epigenetic alterations and dysregulation of multiple classes of SNX19 transcripts. Expand
Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study
TLDR
The data does not support the role of the rare compound heterozygous SPATA7 missense variations p.Asp134Gly and p.Ile332Thr in conferring a substantial risk of schizophrenia. Expand
Overview: neuroplasticity and synaptic function in neuropsychiatric disorders
  • F. Sengpiel
  • Medicine, Chemistry
  • The Journal of physiology
  • 2018
TLDR
What is known about the mechanisms by which mutations in different loci disrupt synaptic plasticity is reviewed, including disrupted-in-schizophrenia 1 (DISC1) and fragile X mental retardation protein (FMRP) are reviewed. Expand
Assessment of de novo copy-number variations in Italian patients with schizophrenia: Detection of putative mutations involving regulatory enhancer elements
  • G. Piluso, P. Monteleone, +22 authors M. Maj
  • Biology, Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2019
TLDR
These findings provide further evidence for the involvement of de novo CNVs in the pathogenesis of schizophrenia and suggest that CNVs affecting regulatory enhancer elements could contribute to the genetic vulnerability to the disorder. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 138 REFERENCES
Common variants conferring risk of schizophrenia
TLDR
Findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition. Expand
Common variants on chromosome 6p22.1 are associated with schizophrenia
TLDR
It is demonstrated that common schizophrenia susceptibility alleles can be detected and the characterization of these signals will suggest important directions for research on susceptibility mechanisms. Expand
Increased exonic de novo mutation rate in individuals with schizophrenia
TLDR
This study sequenced the exomes of 14 schizophrenia probands and their parents to identify 15 de novo mutations (DNMs) in eight probands, which is significantly more than expected considering the previously reported DNM rate. Expand
Molecular genetics of schizophrenia.
TLDR
To enable further progress there is a need to collect fine-grained clinical datasets while searching the schizophrenia phenotype for subgroups or dimensions that may provide a more direct route to causative genes, and integrate recent refinements in molecular genetic technology. Expand
Genomewide association for schizophrenia in the CATIE study: results of stage 1
TLDR
These data do not provide evidence for the involvement of any genomic region with schizophrenia detectable with moderate sample size, however, a planned genomewide association study for response phenotypes and inclusion of individual phenotype and genotype data from this study in meta-analyses hold promise for eventual identification of susceptibility and protective variants. Expand
Research review: Polygenic methods and their application to psychiatric traits.
TLDR
Genome-wide genotyping and sequencing studies are providing evidence that psychiatric disorders are truly polygenic, that is they have a genetic architecture of many genetic variants, including risk variants that are both common and rare in the population. Expand
Molecular genetic gene–environment studies using candidate genes in schizophrenia: A systematic review
TLDR
This systematic review aims to summarize the results from molecular genetic candidate studies and to review challenges and opportunities of this approach in psychosis research, and to discuss the potential of future prospects. Expand
Common variant at 16p11.2 conferring risk of psychosis
TLDR
Combined analysis reveals a novel variant at 16p11.2 showing genome-wide significant association with schizophrenia and is located within a 593-kb region that substantially increases risk of psychosis when duplicated. Expand
A polygenic burden of rare disruptive mutations in schizophrenia
TLDR
Analysis of exome sequences of schizophrenia cases and controls shows a polygenic burden primarily arising from rare, disruptive mutations distributed across many genes, suggesting that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease. Expand
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics
  • A. Schmitt, D. Rujescu, +17 authors P. Falkai
  • Psychology, Medicine
  • The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2016
TLDR
A comprehensive review of recent efforts to identify genetic underpinnings, clinical and cognitive endophenotypes and symptom dimensions of schizophrenia and findings from neuroimaging studies with structural, functional and spectroscopy magnetic resonance imaging and positron emission tomography identifies several biomarkers that are potential candidates for future research. Expand
...
1
2
3
4
5
...